930 WINTER STREET, WALTHAM, MA
Annual Report to Security Holders
Andrew King Appointed President, Research & Development at Jade Biosciences
Jade Biosciences Approves 2026 Employment Inducement Stock Plan
Financial Results, Press Release
Jade Biosciences Targets 2026 Goals for Monoclonal Antibodies in Autoimmune Diseases
Announces $45 Million Private Placement
Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Investor Presentation
Q1
FY 2025
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Post-Effective Amendment
Amended Schedule 13D - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership